June 12, 2021
Article
Results from the START study of medication switching in narcolepsy were presented at the 2021 SLEEP Annual Meeting.
Video
The director of the Sleep-Wake Disorders Center at Montefiore Medical Center discussed the formulaic background of FT218 and why it’s so effective in treating sleep disorders.
When paired with the Percept PC device, SenSight expands on BrainSense technology, enabling clinicians to capture and record enhanced, directional local field potential information from the implanted lead.
Neurology News Network for the week ending June 12, 2021.
June 11, 2021
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 11, 2021.
The medical director of the Westport Headache Institute shared her insight into the use of the e-TNS device and the role of neuromodulation in migraine.
The FDA-approved agent demonstrated meaningful reduction in the frequency of cataplexy attacks in adults with narcolepsy, including patients with a high symptom burden.
Richard S. Isaacson, MD, and Marc E. Agronin, MD, discuss the recent approval of aducanumab and questions around its appropriate use in people with Alzheimer disease.
Alzheimer disease experts Richard S. Isaacson, MD, and Marc E. Agronin, MD, discuss the recent aducanumab approval and some of the clinical community's concerns.
The nurse practitioner at the Woodruff School of Nursing at Emory University detailed why advanced practice clinicians should be utilized more in neurology settings.
